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Edited by Vladimir SkulachevAbstract Poly(L-lysine)s, PLLs, are commonly used for DNA
compaction and cell transfection. We report that, although PLLs
of low (2.9 kDa), L-PLL, and high (27.4 kDa), H-PLL, Mw in
free form and DNA-complexed cannot only cause rapid plasma
membrane damage in human cell lines, phosphatidylserine
‘‘scrambling’’ and loss of membrane integrity, but later (24 h) ini-
tiate stress-induced cell death via mitochondrial permeabilization
without the involvement of processed caspase-2. Mitochondrially
mediated apoptosis was conﬁrmed by detection of cytochrome c
(Cyt c) release, activation of caspases-9 and -3, and subsequent
changes in mitochondrial membrane potential. Plasma membrane
damage and apoptosis were most prominent with H-PLL. Cyto-
plasmic level of Cyt c was more elevated following H-PLL
treatment, but unlikeL-PLLcase, inhibition ofBax channel-form-
ing activity reduced the extent of Cyt c release from mitochondria
by half. Inhibition of Bax channel-forming activity had no
modulatory eﬀect on L-PLL-mediated Cyt c release. Further,
functional studies of isolated mitochondria indicate that H-PLL,
but not L-PLL, can directly induce Cyt c release, membrane depo-
larization, and a progressive decline in the rate of uncoupled respi-
ration. Combined, our data suggest that H-PLL and L-PLL are
capable of initiating mitochondrially mediated apoptosis diﬀer-
ently. The observed PLL-mediated late-phase apoptosis may
provide an explanation for previously reported transient gene
expression associated with PLL-based transfection vectors. The
importance of our data in relation to design of novel and safer
cationic non-viral vectors for human gene therapy is discussed.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Poly(ethylenimine)1. Introduction
Recently, we demonstrated that both linear- and branched-
poly(ethylenimine), PEI-L and PEI-B, which are used com-Abbreviations: L-PLL, low molecular weight poly(L-lysine); H-PLL,
high molecular weight poly(L-lysine); Cyt c, cytochrome c; PEI, poly
(ethylenimine); PEI-B, branched-PEI; PEI-L, linear-PEI; PS, phos-
phatidylserine; LDH, lactate dehydrogenase; MMP, mitochondrial
membrane potential; FCCP, triﬂuoromethoxy carbonyl cyanide phenyl-
hydrazone; DNP, dinitrophenol
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doi:10.1016/j.febslet.2005.09.092monly in gene transfer protocols, induced apoptosis in a number
of clinically relevant human cell lines by initiating cytochrome c
(Cyt c) release through direct channel formation in the outer
mitochondrial membrane and subsequent activation of execu-
tioner caspases [1]. Synthetic polyamines such as linear and den-
dritic poly(L-lysine)s, PLL, and variations thereof, have also
been used for DNA compaction and transfection with variable
results [2–8]. Following internalization, these complexes localize
to early endocytic vesicles. In the absence of an endosomotropic
agent, such as chloroquine and inﬂuenza virus hemagglutinin
HA-2-based fusogenic peptides [4,9], PLL–DNA complexes do
not eﬃciently escape from endosomes, but gene expression still
occurs [9]. In light of our observations with poly(ethylenimine)
(PEI) [1], and inherent cytotoxicity of PLLs [5,8,10,11], we
sought to investigate whether high and low molecular weight
PLLs (H-PLL and L-PLL) in linear form, which are routinely
used in transfection protocols, can induce apoptosis in diﬀerent
types of human cell lines (Jurkat T-cells, umbilical vein endothe-
lial cells, and THLE-3 hepatocyte-like cell line), and if so
through what mechanisms. These studies are critical, particu-
larly with the view that the intracellular levels of endogenous
polyamines (e.g., spermine and spermidine) are tightly regulated
by means of several homeostatic mechanisms, whereas their
excessive cytoplasmic accumulation (e.g., resulting from insults
to anionic cellular structures) transduces a death signal to mito-
chondria by an oxygen-independent mechanism [12,13]. For in-
stance, ubiquitous spermine at a concentration of 10 lM can
induce the release of discrete amounts of Cyt c from functional
coupled mitochondria rapidly in a saturable manner [13]. In
addition, understanding ofmolecularmechanisms of polycation
cytotoxicity is of immense importance in gene therapyprotocols,
which intend to restore gene function as in, inherited genetic dis-
orders. Here, for the ﬁrst time we identify PLLs as apoptotic
agents, but remarkably we show that PLLs of low and high
molecular weights, both in free form as well when complexed
with mammalian DNA, initiate stress-induced apoptosis via
mitochondrial permeabilization diﬀerently.2. Materials and methods
2.1. Complex preparation and characterization
High (Mw = 27.4 kDa) and low (Mw = 2.9 kDa) molecular weight
PLLs (H-PLL and L-PLL, respectively) and calf-thymus DNA were
from Sigma Chemical Company, UK. PLL–DNA complexes were
formed in 1.5 ml Eppendorf tubes by adding calf-thymus DNA, ination of European Biochemical Societies.
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(PLL:DNA weight ratio, 1:1 and 3:1) and were left for 15 min at room
temperature. Complexes were diluted with ﬁltered HEPES buﬀer for
size and electrophoretic mobility measurements at 25 C by using a
Zetasizer 3000 system (Malvern Instruments, UK) [1]. The size of all
complexes was in the range of 55–105 nm in diameter; L-PLL–DNA
complexes were usually in the lower size region. The zeta potential val-
ues for all complexes composed of PLL:DNA in weight ratio of 3:1
were positive, and was in the range of 7–12 mV (for L-PLL–DNA
complexes) and 17–25 mV (for H-PLL–DNA complexes). For 1:1
weight ratio, PLL–DNA complexes exhibited zeta potential values,
which were close to neutrality.
2.2. Lactate dehydrogenase (LDH) and phosphatidylserine (PS)
externalization assays
Free PLL and PLL–DNA complexes were diluted with serum free
media and added to 1 · 106 Jurkat T-cells (Clone E6-1, American Type
Culture Collection, Manassas, VA), THLE-3 hepatocyte like-cells
(American Type Culture Collection) and human umbilical vein endo-
thelial cells (HUVEC) in 1 ml of serum free RPMI 1640 (Invitrogen,
UK) in triplicate incubations. Final concentration of DNA was
10 lg per sample and PLL concentration was varied between 10 and
30 lg/ml to mimic routine transfection conditions. As negative control,
untreated cells were diluted with the same volume of media used to
prepare polycations. Cells were also challenged with 10 lg calf-thymus
DNA in the absence of PLL. Cells were then incubated at 37 C and
5% CO2. Following incubation with PLL in free form and PLL–
DNA complexes, cells were pelleted and then re-suspended in 250 ll
of binding buﬀer (DAKO, Glostrup, Denmark) for double staining
with annexin V-FITC and propidium iodide according to the manufac-
turers protocol. For a positive control, doxorubicin hydrochloride
(50 lg/ml ﬁnal concentration), a potent pro-apoptotic agent, was used.
Cell-associated ﬂuorescence distributions were obtained from 20000
events per cell sample through a FL-1 band-pass ﬁlter (annexin V-
FITC binding) and FL-3 band-pass ﬁlter (propidium iodide) using a
Becton Dickinson FACScan [1]. Data analysis was performed with
Becton Dickinsons CellQuest software. To assess LDH release, sam-
ples were also taken at appropriate times, centrifuged at 2000 · g for
5 min to pellet. The released LDH was measured using Promegas
(Southampton, UK) CytoTox 96 Non-Radioactive Cytotoxicity Assay
[1]. Samples were read using a plate reader set to 492 nm. TotalFig. 1. The eﬀect of PLLs on PS translocation and caspase-3 activity in Jurka
time-dependent PS externalization in Jurkat T-cells. Similar results were obta
D) show the eﬀect of free PLL concentration on the activity of caspase-3 in Ju
but not in the presence of the inhibitor Ac-DEVD (+I); doxorubicin (Dox)cytotoxicity was calculated by comparing the levels of released LDH
in the experimental samples to total levels of cellular LDH obtained
by lysing 1 · 106 of corresponding cells with Promega cell lysis buﬀer.
2.3. Caspase analysis
The Caspase-3 Colorimetric Assay Kit (Sigma, UK) was used. A
speciﬁc caspase-3 inhibitor, Ac-DEVD-Chinese Hamster Ovary (Ac-
DEVD-CHO), was also included in matched assay samples. The activ-
ity of caspases 2, 3, 8, and 9 were measured simultaneously with the
BD ApoAlert Caspase Assay Plates (BD Biosciences, USA) at
24 h-post PLL and PLL-DNA complex treatment in cells, in accor-
dance with the manufacturers protocol. All measurements were per-
formed in triplicate incubations.
2.4. Determination of cytoplasmic Cyt c levels in cells
Quantitative release of Cyt c from cells at 24 h-post PLL and PLL–
DNA complex challenge was also monitored in the presence a cell-per-
meable Bcl-2 inhibitor (4 lM), which competes with Bak BH3 peptide
for binding to Bcl-2 and Bcl-xL, as well as a cell-permeable Bax channel
blocker (5 mM). The Bcl-2 inhibitor [14] was a mixture of the tautomers
2,9-dimethoxy-11,12-dihydrodibenzo[c,g][1,2]-diazocine-5,6-dioxide
and 5,5 0-dimethoxy-2,2 0-dinitrosobenzyl (MERCK Biosciences, UK).
The Bax channel blocker [15] was (±)-1-(3,6-dibromocarbazol-9-yl)-3-
piperazin-1-yl-propan-2-ol, bis TFA (MERCK Biosciences, UK).
Cyt c release was measured using Zymed Cyt c ELISA kit (Invitro-
gen, UK) in accordance with the manufacturers protocol in triplicate
incubations.
2.5. Mitosensor assay (measuring changes in mitochondrial membrane
potential, MMP)
The speciﬁc MMP ﬂuorescent probe JC-1 was used to determine
MMP in cells following PLL and PLL–DNA complex treatment [1].
Brieﬂy, cells following treatment with PLL and PLL–DNA complexes
were centrifuged and resuspended in 1 ml of Mitosensor buﬀer con-
taining 1 ll Mitosensor reagent (BD Biosciences, Oxford, UK) as de-
scribed elsewhere [1]. The Mitosensor reagent forms aggregates in
cells with a high FL-2 (585 nm) ﬂuorescence indicating a normal
MMP. Loss of the MMP results in a reduction in FL-2 ﬂuorescence
with a concurrent gain in FL-1 (530 nm) ﬂuorescence as the dye shifts
from an aggregate to monomeric state. Retention of the dye in cells cant T-cells. Panels (A and B) show the eﬀect of free L-PLL and H-PLL on
ined with respective PLL–DNA complexes (not shown). Panels (C and
rkat T-cells. Caspase-3 activity was detectable 24 h post-PLL treatment
is the positive control.
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was calculated by comparing changes between control and treated cells
in the green FL1 (530 nm) and red/orange FL2 (560–585 nm) ﬂuores-
cent channels.2.6. Mitochondrial isolation and functional tests
Isolated rat liver mitochondria were obtained by cell disruption and
diﬀerential centrifugation in a medium containing 225 mM mannitol,
75 mM sucrose, 3 mM Tris–HCl (pH 7.4), and 0.1 mM EGTA. The
ﬁnal wash was in the same medium but without EGTA. The relative
purity of mitochondrial preparation was determined using 5 0-nucleo-
tidase, acid phosphatase, glucose-6-phosphate and succinate dehydro-
genase assays as representative markers of plasma membranes,
lysosomes, endoplasmic reticulum and mitochondria, respectively.
The relative enzyme activity/mg protein was compared between the
mitochondrial fraction and a crude liver homogenate. Enzyme analysis
conﬁrmed that mitochondrial preparation was enriched for succinate
dehydrogenase with minimal contamination by other organelles as
compared with the crude liver preparation (5 0-nucleotidase, acid phos-
phatase, glucose-6-phosphate and succinate dehydrogenase activity/mg
protein of 0.17 ± 0.04, 0.34 ± 0.05, 0.025 ± 0.03 and 4.95 ± 0.07,
respectively, relative to the crude liver homogenate). All mitochondrial
functional measurements (n = 6) were performed at a mitochondrial
protein concentration of 1.5 mg/ml. Mitochondrial swelling was mon-
itored continuously as changes in A540 at 25 C; 250 lMCa2+ was used
as positive control [1]. Western blot analysis was used to determine CytFig. 2. The eﬀect of PLL–DNA complexes on caspase 3 activity in three diﬀe
L-PLL–DNA and H-PLL–DNA type complexes on caspase activity, respect
complex treatment. PLL:DNA of 1:1 and 3:1 represent 10 lg PLL:10 lg DNc release from isolated mitochondria at 10 min post-treatment with dif-
ferent concentrations of polycations (PLL and PEI). For positive con-
trol, 0.5 mM Ca2+ was used. Following the secondary antibody
incubation, the nitrocellulose membranes were rinsed, and bound anti-
bodies were detected using enhanced Amershams Pharmacia Biotech
(UK) chemiluminescence detection system [1].
Oxygen consumption by isolated mitochondria was measured using
a Clark-type oxygen electrode (Yellow Spring Instrument Co., Yellow
Spring, OH, USA) at 25 C in treatment buﬀer (125 mM KCl, 25 mM
HEPES (pH 7.4), 5 mM NaCl, 1 mM KH2PO4, 1 mM MgCl2, 5 mM
malate, 10 mM glutamate and 0.5 mM Na2EDTA). For uncoupling
of oxidative phosphorylation, dinitrophenol (DNP), 100 lM, was
used. Following polycation challenge, the mitochondrial membrane
potential was estimated using 8 lM safranine at 25 C in a 3-ml cuvette
of a Shimadzu RF 5000 spectroﬂuorimeter (Tokyo, Japan) in the treat-
ment buﬀer [1]. For complete depolarization, the uncoupler triﬂuoro-
methoxy carbonyl cyanide phenylhydrazone, FCCP, (2 lM) was used.3. Results and discussion
The results in Fig. 1A and B demonstrate that incubation of
Jurkat T-cells with PLL causes PS translocation from the inner
plasma membrane to the outer cell surface detectable by the
ﬂuorochrome-conjugated annexin V; this could be attributedrent types of human cell lines. Panels (A) and (B) represent the eﬀect of
ively. Caspase activity was determined 24 h post-PLL and PLL–DNA
A/incubation and 30 lg PLL:10 lg DNA/incubation, respectively.
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tion is most rapid (30 min–1 h) with H-PLL at concentrations
of 20 lg/ml and above, whereas PS exposure is notable from
5 h post-incubation with L-PLL. Similar results were also ob-
tained with THLE-3 hepatocytes and HUVECs (data not
shown). We also found a substantial delay between PS expo-
sure and activation of the executioner caspase-3, the protease
responsible for cleavage of the majority of caspase substrates
during apoptosis. The activity of this protease was profound
particularly at 24 h-post-PLL (20 lg/ml) treatment, was
regardless of PLL type (Fig. 1C and D) and could be inhibited
by Ac-DEVD (a caspase-3 inhibitor). H-PLL was more eﬀec-
tive than L-PLL in inducing caspase-3 activation. Also, cas-
pase-3 activation was detectable at 24 h-post-treatment with
lower concentrations of both PLL types (10 lg/ml); this was
in accord with PS expression in tandem with propidium iodide
staining. We also obtained similar results with PLL–DNA
complexes, and also in diﬀerent types of human cell lines,
Fig. 2. However, HUVECs were signiﬁcantly less responsive
to L-PLL/L-PLL–DNA complexes than Jurkat T-cells and
THLE-3 hepatocytes (Fig. 2).
Hence, both PLL types induce apoptosis, but early exposure
of PS (30 min to 5 h) is presumably the result of plasma mem-Fig. 3. Time-dependent LDH release from Jurkat T-cells following treatment
eﬀect of L-PLL–DNA and H-PLL–DNA type complexes on LDH release, r
errors where within 5% of the mean values.brane damage and phospholipid re-shuﬄing following electro-
static interaction with PLL and PLL–DNA complexes; early
PS expression (during the ﬁrst 5 h) was not aﬀected in the pres-
ence of Ac-DEVD and therefore is independent of caspase 3
activation (data not shown). This is further supported by the
observation that caspase 3 activation does not occur during
the ﬁrst 5 h of incubation (Fig. 1C and D). Further, both
PLL and PLL–DNA complexes (at diﬀerent charge ratios,
which resemble routine transfection conditions) caused rapid
LDH release from all tested cell lines (Fig. 3), an observation
consistent with earlier reports on polycation-induced cellular
cytotoxicity [5,8,10,11]. However, L-PLL was least toxic at
early hours of exposure. Therefore, similar to polycationic
PEI [1], we conclude two modes of cytotoxicity with PLLs;
early plasma membrane damage followed by late-phase
(24 h) apoptosis.
Next, we tried to identify through which of the two primary
caspase activation pathways, mitochondrially mediated and
death-receptor-mediated [18], PLLs and PLL–DNA complexes
induce apoptosis. Here, we used PLL–DNA complexes that
express positive zeta potential values (PLL:DNA of 3:1), thus
mimicking previous transfection protocols. Mitochondria are
believed to be a central regulatory element in stress-inducedwith PLL and PLL–DNA complexes. Panels (A) and (B) represent the
espectively. The results represent mean of three incubations; standard
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meabilization and causes the release of proapoptotic proteins
such as Cyt c and Smac/DIABLO from mitochondrial inter-
membrane space [18,19]. Cyt c release initiates apoptosis via
Apaf-1-containing apoptosome complex assembly, and subse-
quent cleavage of caspase-9, which, in turn, activates caspase-
3. The results in Fig. 4A show signiﬁcant accumulation of Cyt
c in Jurkat T-cell cytoplasm at 24 h post-PLL (both in free
form as well as DNA-bound) treatment. However, more Cyt
c was released with H-PLL treatment than L-PLL. A balance
between members of Bcl-2-family proteins is thought to deter-
mine whether mitochondria remain intact or become perme-
abilized and release death-promoting proteins, thereby
accelerating cell disassembly [19,20]. For example, Bcl-2 itself
inhibits cell death, whereas Bax and Bak promote apoptosis.
In the case of H-PLL, the extent of Cyt c release was decreased
by approximately 50% in the presence of a cell-permeable Bax
channel blocker [15], but interestingly inhibition of Bax chan-
nel-forming activity had no eﬀect on Cyt c release from mito-
chondria by L-PLL (Fig. 4A). Similar observations were made
with both free and DNA-bound PLLs. As a control experi-
ment, Bcl-2 inhibition [14] accelerated cell death in all cases
(Fig. 4A). Therefore, we conclude that H-PLL and L-PLL ini-
tiate mitochondrial-mediated apoptosis diﬀerently. In line with
increased cytoplasmic Cyt c accumulation and concomitantµ µ
Fig. 4. The eﬀect of PLLs and PLL–DNA complexes on Cyt c release from
shows quantitative release of Cyt c from Jurkat T-cells at 24 h-post-PLL a
concentrations of 30 and 10 lg/ml, respectively) challenge. Cyt c release was a
well as a cell-permeable Bax channel blocker (5 mM). Panel (B) demonstrate
complex treatment in Jurkat T-cells.with caspase-3 activation, we also detected signiﬁcant cas-
pase-9 activity thus conﬁrming the involvement of mitochond-
rially mediated apoptotic pathway (Fig. 4B). It is also known
that the loss of MMP follows Cyt c release and can be cas-
pase-dependent [21]. Indeed, MMP in Jurkat T-cells was dra-
matically altered in a time-dependent manner; this was
consistent with caspase activation (peak activity at 24 h), as
determined by the speciﬁc cationic MMP ﬂuorescent probe
JC-1, which ﬂuoresces diﬀerently in healthy and apoptotic cells
(Fig. 5) [1]. JC-1 forms aggregates in healthy mitochondria
with a high orange/red ﬂuorescence (Fig. 5A and C), indicating
a normal MMP, but following MMP loss these aggregates dis-
sipate into the cytoplasm in the monomeric state, which is
detectable with a concurrent gain in green ﬂuorescence
(Fig. 5B and D).
Nuclear accumulation of PLL–DNA complexes was previ-
ously suggested to occur within a few hours of incubation
[22,23], where PLL may induce genotoxic stress. Recent evi-
dence indicates that caspase-2 is activated in response to geno-
toxins; activated caspase-2 directly permeabilizes the outer
mitochondrial membrane and stimulates the release of death
promoting proteins without the involvement of mitochondrial
permeability transition [24,25]. However, we found no evi-
dence for caspase-2 activation even after prolonged periods
following PLL and PLL–DNA complex challenge (Fig. 4B),µ
mitochondria, Bax channel activity, and caspase activation. Panel (A)
nd PLL–DNA complex (weight ratio, 3:1, with ﬁnal PLL and DNA
lso monitored in the presence a cell-permeable Bcl-2 inhibitor (4 lM) as
s the activity of four diﬀerent caspases 24 h-post-PLL and PLL–DNA
Fig. 5. Time-dependent changes in mitochondrial membrane potential (MMP) in Jurkat T-cells by PLL-DNA complexes. There was no change at
MMP at 1 h (not shown); peak MMP loss was at 24 h post-treatment with L-PLL-DNA complexes (A and B) and H-PLL-DNA complexes (C and
D). Shaded area represents healthy cells at 0 h. Identical results were obtained with PLLs in free form (not shown). DNA had no eﬀect on MMP [1].
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tropic chloroquine (data not shown). Likewise, the absence of
caspase-8 activity (Fig. 4B) further suggests that plasma mem-
brane manipulation by PLLs and PLL–DNA complexes have
no eﬀect on death receptor signalling, which could lead to acti-
vation of caspase-3 and -7 directly or indirectly via subsequent
cleavage of the amino portion of cytosolic Bid to generate
truncated Bid, which, in turn activates proapoptotic Bax or
Bak proteins to release Cyt c from mitochondria [18].
In light of the observed discrepancy on the mode of Cyt c
release from mitochondria by L-PLL and H-PLL (L-PLL-
mediated Bax-independent, and partially Bax-dependent H-
PLL triggered Cyt c release) we turned our attention towards
direct eﬀect of PLLs on mitochondrial membrane permeabili-
zation and physiological functions, using freshly isolated rat li-
ver mitochondria. L-PLL had no eﬀect on mitochondrial
volume, respiration rate and transmembrane potential (data
not shown). Neither it stimulated Cyt c release from the mito-
chondrial intermembrane space when tested at a concentration
up to 30 lg/ml (Fig. 6A). On the contrary, H-PLL treatment
was associated with considerable amounts of Cyt c release; this
was more eﬀective than mitochondrial treatment with either
PEI-B or PEI-L, Fig. 6A. Furthermore, unlike PEIs [1], H-
PLL induced a progressive decline in the rate of DNP uncou-
pled respiration (Fig. 6B) and partial mitochondrial depolar-
ization (Fig. 6C). These observations were not related to
mitochondrial swelling; H-PLL had no eﬀect on mitochondrial
swelling even at up to 100 lg/ml (data not shown). Thus, the
eﬀect of L-PLL and H-PLL on isolated mitochondria are not
only diﬀerent from each other, but also diﬀer from that of
PEI [1], Fig. 6D. The evolutionarily highly conserved region
of Cyt c contains a cluster of 19 positively charged lysine res-
idues and 2 positively charged arginines, which mediate itsinteraction with cardiolipin and the proteins of the electron
transport chain that it shuttles electrons between. Thus, H-PLL
may interact directly with the outer mitochondrial membrane,
or at contact sites between the outer and inner mitochondrial
membranes, where Bcl-2 appear to cluster [26]; this could mod-
ulate the concentration or distribution of cardiolipin, hence
facilitating Cyt c release directly, altering mitochondrial ener-
gization, which enhances Bax docking [27], and subsequent
Bax-mediated mitochondrial destabilization/permeabilization.
Nevertheless, these studies further conﬁrm as to why cell treat-
ment with H-PLL induces signiﬁcantly more caspase-3 activa-
tion than that of L-PLL.
It is intriguing that observations of signiﬁcantly higher Cyt c
release from isolated mitochondria were restricted to H-PLL.
The molecular basis of small amounts of Cyt c release following
cell treatment with L-PLL, however, remains unexplained but
we speculate on some possibilities. Earlier, the endogenous poly-
amine spermine was suggested to facilitate the release of a small
fraction of Cyt c from isolated mitochondria through an
exchangeable sub-population of this protein and without incur-
ring mitochondrial damage [13], but in light of our observations
in intact cells this mode of exit cannot explain L-PLL-induced
Cyt c release. However, PLLs and polyarginines are known to
stimulate a number of cellular kinases andprotein phosphatases,
particularly phospholipases, even at sub-optimal cytotoxic con-
centrations [11]. For instance, PLLwas shown recently to induce
phospholipase D activation in bovine pulmonary artery endo-
thelial cells through the involvement of protein kinase C [11].
Thus, phospholipase activation, presumably throughPLL-med-
iated plasma membrane damage and involvement of protein ki-
nases, may lead towards insertion of lysolipids into the outer
mitochondrial membrane via recently identiﬁed lipid transfer
capacity of full-length Bid [28]. Once bound to lysolipid, full-
Fig. 6. The eﬀect of PLL on mitochondrial membrane permeabilization and physiological functions. Panel (A) shows Cyt c release from
mitochondria 10 min after PLL treatment. Western blot analysis (top segment) demonstrate that L-PLL, but not H-PLL, is unable to release Cyt c
when tested up to 30 lg/ml. For comparison, mitochondrial Cyt c release was also monitored in the presence of PEI-B and PEI-L (30 lg/ml) with
corresponding molecular weights of 25 and 750 kDa, respectively. However, all Cyt c-releasing polycations were eﬀective in their task with
concentrations as low as 0.3 lg/ml (not shown). For positive control, 0.5 mM Ca2+ was used. The lower segment of panel (A) shows the extent of Cyt
c release with respect to the positive control (calcium) and all values are subtracted from the background (Con). Panel (B) shows the ability of H-PLL
in suppressing mitochondrial respiration rate, **P < 0.01. Panel (C) is a typical representative of six separate experiments and show that H-PLL is
capable of aﬀecting mitochondrial transmembrane potential, but for complete depolarization the presence of an uncoupler, triﬂuoromethoxy
carbonyl cyanide phenylhydrazone, FCCP (2 lM), is necessary. Panel (D) compares the eﬀect of PLLs to that of PEIs on isolated rat liver
mitochondrial functions (SW = mitochondrial swelling; DEP = mitochondrial depolarization; ﬂRES = decline in the rate of DNP uncoupled
respiration; Cyt c Rel = cytochrome c release).
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branes rich in cardiolipin and monolysocardiolipin, towards
which the protein has a static selectivity of binding, thereby
altering cardiolipin homoeostasis [28]. Indeed,monolysocardio-
lipin is an inhibitor of mitochondrial phospholipase A2 [29],
thus tight binding of full-length Bid to monolysocardiolipin
may lead to activation of this phospholipase too. These modiﬁ-
cations could collectively alter the physical state of the outer
mitochondrial membrane (e.g., a positive change in membrane
curvature) leading to the release of a small pool of apoptogenic
factors, either directly or through other mediators including
PLL. Indeed, this plausible mechanism may be operative with
both PLL types, but the validity of this hypothesis remains to
be tested when mutant cells become available.
In summary, we have demonstrated that H-PLL and L-PLL
are not only cytotoxic through plasma membrane perturba-
tion/damage, but additionally they are capable of initiating
apoptosis diﬀerently via the mitochondrial pathway. These ef-
fects were reproducible in three diﬀerent human cell lines, with
diﬀerent mitochondrial contents. Notably, we demonstrated
that even in the absence of endosomotropic agents, PLL and
PLL–DNA complexes could induce late-phase mitochon-
drial-mediated apoptosis, thus corroborating their cytoplasmic
presence at around 24 h post-challenge. It may seem necessaryto assess direct localization of PLLs in mitochondria in intact
cells, for example by tagging PLL molecules with ﬂuorescent
markers, and simultaneously assessing their co-localization
with mitochondrial tracking dyes. However, such modiﬁca-
tions alter PLL tertiary structure, and could aﬀect the extent
and even the mode of PLL interaction with the outer mito-
chondrial membrane.
It would seem reasonable to conclude that the induction of
PLL-induced apoptosis could depend on a number of factors,
including the cell type that is being aﬀected, the intracellular
levels of cysteine proteases and Bcl-2-family of proteins, and
whether polyamines can subsequently induce marked changes
in the expression of pro- and anti-apoptotic genes since some
PLL–DNA complexes are believed to localize in the nucleus
[22,23]. Nevertheless, our observations are of relevance to pre-
viously reported but poorly understood cytotoxicity and tran-
sient gene expression following PLL-mediated DNA
compaction and transfection both in vitro and in vivo. It
would be interesting to assess whether ‘‘less cytotoxic’’ PLLs,
such as poly(ethyleneglycol)-conjugated PLL [7] and PLL-
grafted imidazoleacetic acid [8] can initiate apoptosis in nor-
mal and various tumour-derived human cell lines. Understand-
ing of polyamine/polycation-mediated apoptosis is of critical
importance for rational design of non-toxic delivery vectors
6198 P. Symonds et al. / FEBS Letters 579 (2005) 6191–6198for DNA compaction and transfection protocols, particularly
by employing high-throughput approaches [30,31].
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